Metabolic alkalosis in a hemodialysis patient - Successful treatment with a proton pump inhibitor

Clinical Nephrology

Volumn 66, Issue 5, 2006, Pages 391-394

  Kirsch, Bernhard M ^a   Sunder Plassmann, G ^a   Schwarz, C ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Acid base disorder; Dialysis; Metabolic alkalosis; PPI therapy

Indexed keywords

PANTOPRAZOLE; PHOSPHATE BINDING AGENT; PROTON; PROTON PUMP INHIBITOR;

ADULT; ARTICLE; CASE REPORT; CLINICAL PROTOCOL; DIALYSATE; DISEASE SEVERITY; EATING DISORDER; FEMALE; HEMODIALYSIS PATIENT; HOMEOSTASIS; HUMAN; KIDNEY FAILURE; KIDNEY POLYCYSTIC DISEASE; LOW DRUG DOSE; MAINTENANCE THERAPY; MEDICAL RECORD; METABOLIC ALKALOSIS; PH; PRESCRIPTION; TREATMENT OUTCOME; ULTRAFILTRATION; UPPER GASTROINTESTINAL TRACT;

EID: 33750866468     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp66391     Document Type: Article

References (13)

1. Aichbichler BW, Zerr CH, Santa Ana CA, Porter JL, Fordtran JS. Proton-pump inhibition of gastric chloride secretion in congenital chloridorrhea. N Engl J Med. 1997; 336: 106-109.
2. Anderson LE, Henrich WL. Alkalemia-associated morbidity and mortality in medical and surgical patients. South Med J. 1987; 80: 729-733.
3. Barton CH, Vaziri ND, Ness RL, Saiki JK, Mirahmadi KS. Cimetidine in the management of metabolic alkalosis induced by nasogastric drainage. Arch Surg. 1979; 114: 70-74.
4. Gerhardt RE, Koethe JD, Glickman JD, Ntoso KA, Hugo JP, Wolf CJ. Acid dialysate correction of metabolic alkalosis in renal failure. Am J Kidney Dis. 1995; 25: 343-345.
5. Inui A, Kobayashi S, Uemoto M, Yoon S, Kasuga M. Metabolic alkalosis and chronic renal failure in a bulimic patient. Nephron. 1997; 76: 362.
6. Madias NE, Levey AS. Metabolic alkalosis due to absorption of "nonabsorbable" antacids. Am J Med. 1983; 74: 155-158.
7. Marx M, Marx C, Luft FC. Dysarthria in a patient with probable acquired chloridorrhea. Am J Kidney Dis. 2003; 42: 1283-1286.
8. Mehler PS, Linas S. Use of a proton-pump inhibitor for metabolic disturbances associated with anorexia nervosa. N Engl J Med. 2002; 347: 373-374 (author reply).
9. Mossner J, Koop H, Porst H, Wubbolding H, Schneider A, Maier C. One-year prophylactic efficacy and safety of pantoprazole in controlling gastroesophageal reflux symptoms in patients with healed reflux esophagitis. Aliment Pharmacol Ther. 1997; 11: 1087-1092.
10. Okada H, Inoue T, Takahira S, Sugahara S, Nakamoto H, Suzuki H. Daytime hypertension, sleep apnea and metabolic alkalosis in a hemodialysis patient - the result of sodium bicarbonate abuse. Nephrol Dial Transplant. 1999; 14: 452-454.
11. Ostermann ME, Girgis-Hanna Y, Nelson SR, Eastwood JB. Metabolic alkalosis in patients with renal failure. Nephrol Dial Transplant. 2003; 18: 2442-2448.
12. Palmer BF, Alpern RJ. Metabolic alkalosis. J Am Soc Nephrol. 1997; 8: 1462-1469.
13. +/K(+)-ATPase. Biochim Biophys Acta. 1993; 1148: 223-233.